{"id":"https://openalex.org/W7055070765","doi":null,"title":"Cancer immunotherapy with monoclonal antibodies blocking the GARP-dependent production of TGF-\u03b21","display_name":"Cancer immunotherapy with monoclonal antibodies blocking the GARP-dependent production of TGF-\u03b21","publication_year":2020,"publication_date":"2020-01-01","ids":{"openalex":"https://openalex.org/W7055070765"},"language":"en","primary_location":{"id":"pmh:oai:dial.uclouvain.be:boreal:238220","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2078.1/238220","pdf_url":null,"source":{"id":"https://openalex.org/S4306400166","display_name":"Digital Access to Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2800384882","host_organization_name":"Harris County Public Library","host_organization_lineage":["https://openalex.org/I2800384882"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/doctoralThesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073531684","display_name":"Gr\u00e9goire de Streel","orcid":"https://orcid.org/0000-0003-2262-9670","observed_orcids":["https://orcid.org/0000-0003-2262-9670"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"de Streel, Gr\u00e9goire","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5073531684"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.7890999913215637,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.7890999913215637,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.12549999356269836,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.055799998342990875,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.9509999752044678},{"id":"https://openalex.org/keywords/tgf-beta1","display_name":"TGF-\u03b21","score":0.7829999923706055},{"id":"https://openalex.org/keywords/garp","display_name":"GARP","score":0.9629999995231628},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9850000143051147},{"id":"https://openalex.org/keywords/tgf-beta1-activation","display_name":"TGF-\u03b21 activation","score":0.8429999947547913},{"id":"https://openalex.org/keywords/integrin-alphavbeta8","display_name":"integrin \u03b1v\u03b28","score":0.925000011920929},{"id":"https://openalex.org/keywords/anti-pd-1-resistance","display_name":"anti-PD-1 resistance","score":0.9430000185966492},{"id":"https://openalex.org/keywords/melanoma-metastasis","display_name":"melanoma metastasis","score":0.8019999861717224},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.7900000214576721},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8679999709129333}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6776999831199646},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6348000168800354},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.6151999831199646},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6093999743461609},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6039000153541565},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5647000074386597},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5616999864578247},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.560699999332428},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5322999954223633},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5303000211715698},{"id":"https://openalex.org/C45121317","wikidata":"https://www.wikidata.org/wiki/Q4927287","display_name":"Blocking antibody","level":3,"score":0.5302000045776367},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5011000037193298},{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.4223000109195709},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.40290001034736633},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.3953999876976013},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.32710000872612},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.323199987411499},{"id":"https://openalex.org/C2983331546","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer therapy","level":3,"score":0.3228999972343445},{"id":"https://openalex.org/C2777702733","wikidata":"https://www.wikidata.org/wiki/Q1356761","display_name":"Immune tolerance","level":3,"score":0.31299999356269836},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.29429998993873596},{"id":"https://openalex.org/C24530287","wikidata":"https://www.wikidata.org/wiki/Q424204","display_name":"Transmembrane protein","level":3,"score":0.28119999170303345},{"id":"https://openalex.org/C2778326572","wikidata":"https://www.wikidata.org/wiki/Q7852668","display_name":"Tumor-infiltrating lymphocytes","level":4,"score":0.27160000801086426},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.2694000005722046},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2621999979019165},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.25999999046325684},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.2572999894618988},{"id":"https://openalex.org/C2779727006","wikidata":"https://www.wikidata.org/wiki/Q426188","display_name":"FOXP3","level":3,"score":0.25270000100135803},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.25189998745918274}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:dial.uclouvain.be:boreal:238220","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2078.1/238220","pdf_url":null,"source":{"id":"https://openalex.org/S4306400166","display_name":"Digital Access to Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2800384882","host_organization_name":"Harris County Public Library","host_organization_lineage":["https://openalex.org/I2800384882"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/doctoralThesis"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2400788583","https://openalex.org/W2113024959","https://openalex.org/W2305458040","https://openalex.org/W7062254789","https://openalex.org/W7021135694","https://openalex.org/W3085152134","https://openalex.org/W4295448963","https://openalex.org/W4414162193","https://openalex.org/W7071003551","https://openalex.org/W6991273317"],"abstract_inverted_index":{"Cancer":[0],"immunotherapies":[1,61],"aim":[2],"at":[3],"inducing":[4],"or":[5,97,210],"stimulating":[6],"anti-tumor":[7,118,208,301],"immune":[8,32],"responses":[9,315],"to":[10,59,86,105,167,239,263,299,312,316],"eliminate":[11],"tumor":[12,16,201,211],"cells":[13,33,96,101],"and":[14,34,65,133,156,206,246,271],"trigger":[15],"regressions":[17,231],"in":[18,109,197,252,276],"patients":[19,70,111],"with":[20,227],"cancer.":[21],"Approaches":[22],"under":[23],"clinical":[24,55,89],"development":[25],"comprise":[26],"cancer":[27,60,92,110,317],"vaccines,":[28],"adoptive":[29],"transfers":[30],"of":[31,48,51,69,91,126,135,144,150,187,232,286],"immunostimulatory":[35,38,310],"antibodies.":[36],"Several":[37],"antibodies":[39,161,229,267],"were":[40],"approved":[41],"by":[42,128,146,172,203,213,225],"regulatory":[43],"agencies":[44],"for":[45],"the":[46,73,88,136,185],"treatment":[47],"various":[49],"types":[50],"cancers.":[52],"Despite":[53],"impressive":[54],"successes,":[56],"response":[57],"rates":[58],"remain":[62],"very":[63],"diverse,":[64],"only":[66],"a":[67,124,287,293,308],"minority":[68],"benefit":[71],"from":[72,292],"currently":[74],"available":[75],"approaches.":[76],"Novel":[77],"approaches":[78],"that":[79,102,165,221,235,248,260,283],"target":[80],"other":[81,141],"immunosuppressive":[82,100,137],"pathways":[83],"are":[84,99,103,113,236],"needed":[85],"increase":[87],"efficacy":[90],"immunotherapies.":[93,318],"Regulatory":[94],"T":[95],"Tregs":[98,129,147,226,245,270],"indispensable":[104],"prevent":[106],"auto-immunity,":[107],"but":[108],"they":[112,116,249],"detrimental":[114],"because":[115],"suppress":[117],"immunity.":[119,302],"Our":[120],"laboratory":[121],"previously":[122],"identified":[123],"mechanism":[125],"immunosuppression":[127],"which":[130,183],"implies":[131],"production":[132,285],"activation":[134,143,171,224],"TGF-\u03b21":[138,145,170,181,192,223,251,274],"cytokine.":[139],"Unlike":[140],"cells,":[142],"requires":[148],"intervention":[149],"two":[151],"transmembrane":[152],"proteins":[153],"named":[154],"GARP":[155],"integrin":[157],"\u03b1v\u03b28.":[158],"We":[159,242],"developed":[160],"against":[162],"GARP:TGF-\u03b21":[163],"complexes":[164],"allow":[166],"selectively":[168],"block":[169],"Tregs.":[173],"These":[174],"could":[175],"provide":[176,258],"significant":[177],"advantages":[178],"over":[179],"global":[180],"inhibition,":[182],"bears":[184],"risk":[186],"undesired":[188],"tumor-promoting":[189],"effects.":[190],"Indeed,":[191],"exerts":[193],"vastly":[194],"diverse":[195],"effects":[196],"cancer,":[198],"supporting":[199],"either":[200],"progression":[202],"favoring":[204],"metastases":[205],"inhibiting":[207,214],"immunity,":[209],"suppression":[212],"malignant":[215],"cell":[216],"proliferation.":[217],"Here,":[218],"we":[219,257],"show":[220],"blocking":[222,284],"anti-GARP:TGF-\u03b21":[228,266],"induces":[230],"mouse":[233],"tumors":[234],"otherwise":[237],"resistant":[238],"anti-PD-1":[240],"immunotherapy.":[241],"found":[243],"GARP-expressing":[244],"evidence":[247,259],"produce":[250],"human":[253],"melanoma":[254],"metastases.":[255],"Finally,":[256],"upon":[261],"administration":[262],"tumor-bearing":[264],"mice,":[265],"directly":[268],"bind":[269],"reduce":[272],"autocrine":[273],"signals":[275],"these":[277],"cells.":[278],"Altogether,":[279],"our":[280],"work":[281],"suggests":[282],"single":[288],"TGF-\u03b2":[289],"isoform":[290],"emanating":[291],"restricted":[294],"cellular":[295],"source":[296],"is":[297],"sufficient":[298],"potentiate":[300],"Anti-GARP:TGF-\u03b21":[303],"mAb":[304],"may":[305],"serve":[306],"as":[307],"new":[309],"drug":[311],"improve":[313],"patient":[314]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2025-10-10T00:00:00"}